[The extrapyramidal symptoms in the combination of lithium long-term lithium therapy with nortriptyline. A case report on the formation of a pathogenesis hypothesis].
D000328:Adult; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D001714:Bipolar Disorder / Q000188:drug therapy; D002749:Chlorprothixene / Q000627:therapeutic use; D003006:Clopenthixol / Q000627:therapeutic use; D003984:Dibenzazepines / Q000627:therapeutic use; D004357:Drug Synergism; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005260:Female; D006801:Humans; D008094:Lithium / Q000009:adverse effects* / Q000627:therapeutic use; D008134:Long-Term Care; D009661:Nortriptyline / Q000009:adverse effects* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D011352:Procyclidine / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D013569:Synapses / Q000187:drug effects; D013881:Thioridazine / Q000627:therapeutic use
D003984:Dibenzazepines; D003006:Clopenthixol; D008094:Lithium; D002749:Chlorprothixene; D011433:Propranolol; D009661:Nortriptyline; D011352:Procyclidine; D013881:Thioridazine
Extrapyramidale Symptomatik bei Kombination der Lithium-Langzeittherapie mit Nortriptylin. Ein kasuistischer Beitrag zur Pathogenese-Hypothesenbildung